Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Meeting ID

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Dec 04, 2024 11:44am

131 Views

Post# 36345300

RE:RE:RE:RE:RE:Meeting ID

Nice. I missed CC as was working. Only listened to last question. Did they say anything about partnerships?

Kayz88 wrote: If I heard correctly:

They resubmitted the preBTD application this week.
The delay was due to the FDA requesting the data to be presented in a different format (so they're not asking for more data)
Expectation for BTD approval in Q1 of 2025

I'm fine with this.